Breast ultrasound significantly increases detection of cancers in high-risk women but takes a big toll in the rate of benign biopsies, according to the initial results of a screening trial sponsored by the American College of Radiology Imaging Network and the Avon Foundation.
Breast ultrasound significantly increases detection of cancers in high-risk women but takes a big toll in the rate of benign biopsies, according to the initial results of a screening trial sponsored by the American College of Radiology Imaging Network and the Avon Foundation.
The ACRIN study of about 2800 women showed that breast ultrasound increased the detection yield over mammography by 4.2 cancers per 1000 high-risk women, said principal investigator Dr. Wendie Berg of American Radiology Services in Lutherville, MD. However, mammography prompted biopsies in 2.6% of cases, 29% of which were positive. In comparison, ultrasound prompted biopsies in 5% of cases, and only 8.8% were positive.
Berg released the data at the 2007 Fall ACRIN meeting in Arlington, VA.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.